προφιλ
- Επιμελήτρια καρδιολόγος Τμήματος Καρδιολογικών Υπερήχων Μetropolitan General
- Μονάδα Καρδιο-ογκολογίας- Α’ Πανεπιστημιακή Καρδιολογική Κλινική, Γ.Ν. Α. Ιπποκράτειο - Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών - Επιστ. Συνεργάτης -Υπεύθυνη τμήματος
ΕΚΠΑΙΔΕΥΣΗ & ΑΚΑΔΗΜΑΪΚΟΙ ΤΙΤΛΟΙ
- 2025: Διδάκτωρ Ιατρικής Σχολής Εθνικού και Καποδιστριακού Πανεπιστημίου Αθηνών
- 2025: Πρόγραμμα μεταπτυχιακών σπουδών «Καρδιακή Ανεπάρκεια - Καρδιο-ογκολογία - Καρδιαγγειακή Αποκατάσταση» - Πανεπιστήμιο Θεσσαλίας
- 2024: Εξειδίκευση στην καρδιο-ογκολογία- Specialty training, Cardio-Oncology Center of Excellence, Amyloid Center of Excellence, Washington University, St . Louis, Missouri, USA
- 2024: Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management- ASNC
- 2024: Level I Competence in Cardiovascular Magnetic Resonance - SOCIATY OF CARDIOVASCULAR MAGNETIC RESONANCE SCMR
- 2023: Εξειδίκευση στις νεότερες υπερηχοκαρδιογραφικές τεχνικές – Γ.Ν.Α. Ιπποκράτειο, Αθήνα
- 2023: Health After Cancer: Cancer Survivorship for Primary Care- Stanford School of Medicine-Stanford University
- 2023: Cancer Survivorship: Optimizing Care and Outcomes- Harvard Medical School - Harvard University
- 2022: Τίτλος Ιατρικής Ειδικότητας Καρδιολογίας
- 2017: Hammersmith Hospital Echocardiography Department - Imperial College, London –United Kingdom (εκπαίδευση στον τομέα της ηχωκαρδιογραφίας)
- 2009: Πτυχίο Ιατρικής (MD in Medicine and Surgery, Universita’ degli studi dell’Aquila (βαθμός: ΑΡΙΣΤΑ)
ΠΡΟΫΠΗΡΕΣΙΑ
- 2023 – σήμερα: Μονάδα Καρδιο-ογκολογίας- Α’ Πανεπιστημιακή Καρδιολογική Κλινική, Γ.Ν. Α. Ιπποκράτειο - Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών - Υπεύθυνη τμήματος
- 2023 – 2026: METROPOLITAN GENERAL - Επιμελήτρια, Ειδικός καρδιολόγος
- 2017: Hammersmith Hospital Echocardiography Department - Imperial College, London –United Kingdom (εκπαίδευση στον τομέα της ηχωκαρδιογραφίας)
- 2016 – 2022: A’ Καρδιολογική κλινική - Γ.Ν.Α Ο Ευαγγελισμός (ειδικευόμενη ιατρός)
- 2014 – 2016: Καρδιολογική κλινική Γενικού Παναρκαδικού Νοσοκομείου -Τρίπολη (ειδικευόμενη ιατρός)
- 2013-2023: Μονάδα Υπέρτασης, Α’ Πανεπιστημιακή Καρδιολογική Κλινική Γ.Ν. Α. Ιπποκράτειο - Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (Επιστημονικός Συνεργάτης)
- 2012 –2013: A’ Παθολογική κλινική Γ.Ν. Καλαμάτας (ειδικευόμενη ιατρός)
- 2010 – 2011: Περιφερειακο Ιατρειο, Κέντρο Υγείας Λογγα- Κ.Υ.Μεσσήνης (Ιατρός Υπερεσίας Υπαίθρου)
ΜΕΛΟΣ ΕΤΑΙΡΕΙΩΝ, ΣΥΝΤΑΚΤΙΚΗΣ ΕΠΙΤΡΟΠΗΣ ΠΕΡΙΟΔΙΚΩΝ
- Ιατρικός Σύλλογος Αθηνών
- Ιατρικός Σύλλογος Πειραιά
- Ελληνική Καρδιολογική εταιρία, EKE
- FESC, ESC Cardio-Oncology Fellow
ΤΙΜΗΤΙΚΕΣ ΔΙΑΚΡΙΣΕΙΣ
Υποτροφία Ελληνικού Ιδρύματος Καρδιολογίας ( ΕΛ.Ι.ΚΑΡ.) - «Βραβείο Μάκη Τσαπόγα_Συμβολή στις Αγγειακές Παθήσεις»
ΔΗΜΟΣΙΕΥΣΕΙΣ/ ΣΥΜΜΕΤΟΧΕΣ ΣΕ ΣΥΝΕΔΡΙΑ
- «Η ΠΕΡΙΚΑΡΔΙΑΚΗ ΝΟΣΟΣ ΣΤΟΥΣ ΟΓΚΟΛΟΓΙΚΟΥΣ ΑΣΘΕΝΕΙΣ» ΚΑΡΔΙΑ ΚΑΙ ΑΓΓΕΙΑ, 2025 ΤΕΥΧ.4, 24-35
- “The Effect of Renal Denervation on Capillary Density in Patients With Uncontrolled Hypertension” Microcirculation. 2025 Jul;32(5):e70015. doi: 10.1111/micc.70015. PMID: 40544439; PMCID: PMC12182759.
- «ΚΑΡΔΙΑΓΓΕΙΑΚΕΣ ΕΠΙΠΤΩΣΕΙΣ ΤΗΣ ΑΚΤΙΝΟΘΕΡΑΠΕΙΑΣ: ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ Ο ΚΑΡΔΙΟΛΟΓΟΣ.» ΚΑΡΔΙΑ ΚΑΙ ΑΓΓΕΙΑ, 2024 ΤΕΥΧ.3, 16-28
- “EFFECTS OF TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE ON LEFT ATRIAL FUNCTION” EuroPCR 2024
- ¨MULTIMODALITY IMAGING APPROACH IN A CASE OF VASCULAR
TOXICITY CAUSED BY CABOZANTINIB¨ Radiology Case Reports, Vol.19, Issue 1, January 2024, pg 62-65 - «ΑΝΕΞΑΡΤΗΤΟΙ ΠΡΟΓΝΩΣΤΙΚΟΙ ΔΕΙΚΤΕΣ ΚΑΡΔΙΑΓΓΕΙΑΚΩΝ
ΣΥΜΒΑΜΑΤΩΝ ΣΕ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΚΙΝΟ» 44th International Congress of Cardiology (Athens,2023) - «ΜΕΤΑΒΟΛΕΣ ΣΤΗ ΛΕΙΤΟΥΡΓΙΚΟΤΗΤΑ ΤΟΥ ΑΡΙΣΤΕΡΟΥ ΚΟΛΠΟΥ ΜΕΤΑ ΑΠΟ ΔΙΑΚΑΘΕΤΗΡΙΑΚΗ ΣΥΓΚΛΕΙΣΗ ΒΑΤΟΥ ΩΟΕΙΔΟΥΣ ΤΡΗΜΑΤΟΣ» 44th International Congress of Cardiology (Athens,2023)
- «ΠΡΟΫΠΕΡΤΑΣΗ. ΠΡΟΓΝΩΣΤΙΚΗ ΣΗΜΑΣΙΑ ΚΑΙ ΑΝΤΙΜΕΤΩΠΙΣΗ» Καρδιά και αγγεία, Μάρτιος- Απρίλιος 2018, τευχ.2, 97-101
- « ΣΤΈΝΩΣΗ ΙΣΘΜΟΎ ΤΗΣ ΑΟΡΤΉΣ: ΤΡΈΧΟΥΣΑ ΘΕΏΡΗΣΗ» Καρδιά και αγγεία,2016 τευχ.2, 89-97
- “EFFECTS OF SARS-COV-2 INFECTION ON THE CARDIORESPIRATORY
PERFORMANCE BY HYPERTENSION STATUS” Journal of Hypertension, Volume 41, Supplement 3 (2023) DOI:https://doi.org/10.1097/01.hjh.0000940808.15711.18 - “CARDIOPULMONARY STATUS AND RIGHT VENTRICLE FUNCTIONALITY IN HYPERTENSIVE PATIENTS HOSPITALIZED OR NOT FOR SARS-COV-2
INFECTION” Journal of Hypertension, Volume 41, Supplement 3 (2023), DOI: https://doi.org/10.1097/01.hjh.0000940804.66185.69 - “EFFECTS OF IVABRADINE ON SYMPATHETIC OVERDRIVE AND ARTERIAL STIFFENING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME: A 6 MONTH FOLLOW-UP STUDY” JACC March 20, 2018Volume 71, Issue 11 (2018)
- BLOOD PRESSURE RESPONSE TO CATHETER-BASED RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION: DATA FROM A NATIONAL MULTICENTER 1-YEAR- FOLLOW-UP STUDY” J Am Coll Cardiol. 2017 Mar, 69 (11_Supplement) 1725 (2017)
- “URIC ACID LEVELS PREDICT CORONARY ARTERY DISEASE BUT NOT STROKE IN ESSENTIAL HYPERTENSION: DATA FROM A GREEK 8-YEAR-FOLLOW-UP STUDY” Cirulation- November 11, 2016 ,Vol 134, Issue suppl_1(2016)
- “EFFECTS OF MULTIELECTRODE RENAL DENERVATION ON SYMPATHETIC NERVE ACTIVITY AND INSULIN RESISTANCE IN METABOLIC SYNDROME” J Am Coll Cardiol. 2016 Nov, 68 (18_Supplement) (2016)
- “CARDIOVASCULAR PROGNOSIS OF COMBINED PATTERNS OF RESISTANT HYPERTENSION AND SMOKING STATUS: A 3.6 YEAR FOLLOW-UP STUDY” J Am Coll Cardiol. 2015 Mar, 65 (10_Supplement) (2015)
- “PREDICTORS AND CARDIOVASCULAR PROGNOSIS OF INCIDENT AND PERSISTENT RESISTANT HYPERTENSION: A 4-YEAR FOLLOW-UP STUDY”- Journal of American College of Cardiology's(2014)
- “EVENING VERSUS MORNING DOSING OF ANTIHYPERTENSIVE DRUGS IN HYPERTENSIVE PATIENTS WITH SLEEP APNEA: A CROSS-OVER STUDY”- Journal of American College Of Cardiology's(2014)
- “COMBINED PATTERNS OF SMOKING AND EXCESS WEIGHT FOR PREDICTION OF CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS: A 4-YEAR FOLLOW-UP STUDY”- Journal of American College of Cardiology's(2014)
- “COMPARISON OF THE PULSE WAVE VELOCITY WITH LEFT VENTRICULAR HYPERTROPHY FOR PREDICTING CORONARY ARTERY DISEASE IN PATIENTS WITH ESSENTIAL HYPERTENSION: DATA FROM 6- YEAR FOLLOW-UP STUDY” - 35th International Congress of Cardiology (Athens,2014)
- “ASSESSMENT OF CARDIOVASCULAR MORTALITY DEPENDING ON THE NATURAL HISTORY OF RESISTANT HYPERTENSION: ANALYSIS 4-YEAR FOLLOW-UP STUDY USING TIME-DEPENDENT VARIABLES” - 35th International Congress of Cardiology (Athens,2014)
- “POSITIVE EFFECT OF IVABRADINE ON SYMPATHETIC OVERACTIVITY AND ARTERIAL STIFFNESS IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME” - 35th International Congress of Cardiology (Athens,2014)
- “PROGNOSTIC FACTORS EMERGING ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS. THE DOMINANT ROLE OF THE LEFT ATRIUM” - 35th International Congress of Cardiology (Athens,2014)
- “THE METABOLIC SYNDROME IS ASSOCIATED WITH A HIGH LEVEL OF STIMULATION OF THE SYMPATHETIC NERVOUS SYSTEM AND INCREASED ARTERIAL STIFFNESS IN PATIENTS WITH RESISTANT HYPERTENSION”- 35th International Congress of Cardiology (Athens,2014)
- “RELATIONSHIP BETWEEN RENAL HEMODYNAMICS AND HEMODYNAMICS OF THE HEART AND AORTA IN EARLY ESSENTIAL HYPERTENSION”- 35th International Congress of Cardiology (Athens,2014)
- “METABOLIC SYNDROME AND DIABETES MELLITUS INDEPENDENTLY PREDICT ADVERSE EVENTS IN ESSENTIAL HYPERTENSIVE SUBJECTS”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “WAIST CIRCUMFERENCE VERSUS OTHER OBESITY PARAMETERS AS DETERMINANTS OF CORONARY ARTERY DISEASE IN ESSENTIAL HYPERTENSION” - Joint Meeting of the ESH and ISH (Athens, 2014)
- “INCIDENT AND PERSISTENT RESISTANT HYPERTENSION DURING LONG TERM FOLLOW-UP IS ACCOMPANIED BY LACK OF REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN ESSENTIAL HYPERTENSIVES” – Joint Meeting of the ESH and ISH (Athens, 2014)
- “RELATIONSHIPS OF METABOLIC SYNDROME AND DIABETES MELLITUS WITH INCIDENT AND PERSISTENT RESISTANT HYPERTENSION IN ESSENTIAL HYPERTENSIVE SUBJECTS”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “PARALLEL DETERIORATION OF ALBUMINURIA AND OXYGEN SATURATION IN ESSENTIAL HYPERTENSION: INTEGRATING VASCULAR DYSFUNCTION”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “CARDIOVASCULAR MORBIDITY ACCORDING TO THE PHYSICAL COURSE OF RESISTANT HYPERTENSION: A TIME UPDATED ANALYSIS OF A 4 YEAR PROSPECTIVE STUDY”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “EFFECTS OF MULTI-ELECTRODE CATHETER-BASED RENAL SYMPATHETIC DENERVATION ON CARDIAC DAMAGE AND NEUROHORMONAL ACTIVATION IN SEVERE DRUG RESISTANT HYPERTENSION”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “EVALUATION OF WHITE COAT HYPERTENSION USING AUTOMATED OFFICE BLOOD PRESSURE VERSUS OFFICE BLOOD PRESSURE MEASUREMENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “RELIABILITY OF AUTOMATED OFFICE BLOOD PRESSURE IN THE ASSESSMENT OF MORNING HYPERTENSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “RELATIONSHIPS BETWEEN RENAL HAEMODYNAMICS WITH CARDIAC AND AORTIC HAEMODYNAMICS IN THE EARLY STAGES OF ESSENTIAL HYPERTENSION”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “COMPARISON OF CARDIOVASCULAR RISK OF RESISTANT HYPERTENSION AGAINST THAT OF SMOKING: A 3.6 YEAR FOLLOW-UP STUDY”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “LACK OF REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IS ACCOMPANIED BY ADVERSE PROGNOSIS IN ESSENTIAL HYPERTENSIVES”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “EVALUATION OF DIURETIC’S EFFICACY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION ASSESSED BY AMBULATORY BLOOD PRESSURE MEASUREMENTS”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “EVALUATION OF THE EVENING DOSAGE OF ANTIHYPERTENSIVE DRUG IN BLOOD PRESSURE CONTROL AND DIPPING STATUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE”- Joint Meeting of the ESH and ISH (Athens, 2014)
- “STUDY OF ARTERIAL HYPERTENSION ON WOMEN IN RURAL POPULATION” - presented at the 3rd National Conference of Pre-Hospital Cardiology (2nd AWARD)
- “DIRECT EFFECTS OF INTENSE PHYSICAL EXERCISE IN HEART RATE AND BLOOD PRESSURE” – 7th Panhellenic Conference Cardiometabolic Risk Factors (Kalamata,2014)
- «LATE MANIFESTATION OF NEUTROPENIC FEVER AS CONSEQUENCE OF ANTITHYROID DRUG SOMMINISTRATION" presented at the 5th Congress of Health of Messinia (2nd AWARD)
- “MANAGEMENT OF ARTERIAL HYPERTENSION ON POST-MENOPAUSAL WOMEN, IMPACT OF LIVING IN CONSOLIDATION AND TREATMENT OF ARTERIAL HYPERTENSION” presented at the 13th National Congress of Hypertension (Greece)
- “BROWN-SEQUARD SYNDROME: PRESENTATION AND FOLLOW UP OF A CASE REPORT” presented at the 1st National Congress of Greek College of General Practitioners (1st AWARD)
- “ADDITIONAL/ALTERNATE TREATMENT SUBSEQUENT TO REFRACTIVE SURGERY TECHNIQUES UNDER TOPOGRAPHICAL GUIDANCE” (i.e. “Ritrattamenti Dopo Interventi Di Chirurgia Rifrattiva Con Tecniche A Guida Topografica”) – THESIS
- “LOW BACK PAIN AS THE FIRST SYMPTOM OF ENDOKARDITIS” presented at the18th National Congress of Internal Medicine
- “TREATMENT OF VRE ENDOCARDITIS WITH DAPTOMYCIN AND MANIFESTATION OF VERTIGO”
